Abstract
The protein target-microarray assay is a hitherto underestimated method in the investigation of protein-ligand/inhibitor and protein-protein/inhibitor-interactions. It is a versatile and adaptable method that can also be used in the diagnostic and individual medicine. Following, examples for target-oriented tests with high potential for development are demonstrated.
Similar content being viewed by others
Literatur
Lindquist S (1986) The heat shock response. Annu Rev Biochem 55:1151–1191
Doyle SM, Genest O, Wickner S (2013) Protein rescue from aggregates by powerful molecular chaperone machines. Nat Rev Mol Cell Biol 14:617–629
Trepel J, Mollapour M, Giaccone G et al. (2010) Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer 10:537–549
Kirschning A, Walter JG, Stahl F et al. (2015) Molecular survival strategies of organisms: HSP and small molecules for diagnostics and drug development. In: Asea AAA, Almasoud NN, Krishnan S et al. (Hrsg) Heat Shock Proteins-Based Therapies, Vol 8. Springer, Cham, S 323–344
Franke J, Eichner S, Zeilinger C et al. (2013) Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy. Nat Prod Rep 30:1299–1323
Eichner S, Eichner T, Floss HG et al. (2012) Broad substrate specificity of the amide synthase in S. hygroscopicus–new 20-membered macrolactones derived from geldanamycin. J Am Chem Soc 134:1673–1679
Schax E, Walter JG, Märzhäuser H et al. (2014) Microarray-based screening of heat shock protein inhibitors. J Biotechnol 180:1–9
Hermane J, Bułyszko I, Eichner S et al. (2015) New, non-quinone fluorogeldanamycin derivatives strongly inhibit Hsp90. Chembiochem 16:302–311
Sharma R, Mohammadi-Ostad-Kalayeh S, Stahl F et al. (2017) Two new labdane diterpenoids and one new β lactam compound from the aerial part of Roylea cinerea. Phytochem Lett 19:101–107
Schax E, Neunaber J, Stahl F et al. (2014) Multiplexed heat shock protein microarray as a screening platform for the selection of novel drug compounds. Biodiscovery 14:1–6
Author information
Authors and Affiliations
Corresponding author
Additional information
Sabine Helmsen 2016 Bachelorabschluss in Chemie an der Universität Hannover. Derzeit Masterarbeit am Biomolekularen Wirkstoffzentrum (BMWZ) über Proteinmikroarrays, Masterstudiengang Analytik.
Vjaceslavs Hrupins 2011–2014 Bachelorstudium Biochemie und 2014–2016 Masterstudium Wirk- und Naturstoffchemie an der Universität Hannover. Master arbeit am Biomolekularen Wirkstoffzentrum (BMWZ) über Proteinmikroarrays. Zurzeit Promotion bei Prof. Dr. R. J. Cox.
Christin Ahlbrecht 2011–2017 Studium Life Science an der Universität Hannover. Masterarbeit am Biomolekularen Wirkstoffzentrum (BMWZ) über Proteinmikro arrays. Zurzeit Promotion bei Prof. Dr. O. Plettenburg.
Frank Stahl Biologiestudium an der Universität Gießen, dort 1998 Promotion bei Prof. Dr. A. **oud am Institut für Biochemie. Postdoc an der Gesellschaft für Biotechnologische Forschung mbh (GBF), Braunschweig. Danach Labormanager, Genedrugs GmbH, Hechingen. Seit 2003 Arbeitsgruppenleiter Chiptechnologien am Institut für Technische Chemie der Universität Hannover.
Carsten Zeilinger Biologiestudium an der Universität Osnabrück, dort 1990 Promotion bei Prof. Dr. E. W. Weiler am Lehrstuhl Pflanzenphysiologie. 1998 Habilitation in Pflanzenphysiologie an der Universität Hannover. Seit 2008 Arbeitsgruppenleiter am Biomolekularen Wirkstoffzentrum (BMWZ), Hannover.
Rights and permissions
About this article
Cite this article
Helmsen, S., Ahlbrecht, C., Hrupins, V. et al. Entwicklung komplexer Screening verfahren am Beispiel von Hsp90. Biospektrum 23, 540–543 (2017). https://doi.org/10.1007/s12268-017-0839-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12268-017-0839-8